Evidence map›Paper›PMID 42448570›Full record

ArticleLife science alliance2026

SATB1 preserves CD4

Wooseok Seo, Chengcheng Zou, Kanako Shimizu, Ruka Setoguchi, Kiyokazu Kakugawa, Terumi Kohwi-Shigematsu, Shohei Hori, Shin-Ichiro Fujii, Hiroyoshi Nishikawa, Ichiro Taniuchi

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Life science alliance, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Wooseok SeoDivision of Cancer Immune Multicellular System Regulation, Center for Cancer Immunotherapy and Immunobiology (CCII), Kyoto University Graduate School of Medicine, Kyoto, Japan seo.wooseok.2i@kyoto-u.ac.jp.ORCID https://orcid.org/0000-0001-6279-166X
Chengcheng ZouLaboratory for Transcriptional Regulation, RIKEN Center for Integrative Medical Sciences (IMS), Yokohama, Japan.
Kanako ShimizuLaboratory for Immunotherapy, RIKEN Center for Integrative Medical Sciences (IMS), Yokohama, Japan.
Ruka SetoguchiLaboratory for Immunogenetics, RIKEN Center for Integrative Medical Sciences (IMS), Yokohama, Japan.
Kiyokazu KakugawaLaboratory for Immune Crosstalk, RIKEN Center for Integrative Medical Sciences (IMS), Yokohama, Japan.
Terumi Kohwi-ShigematsuDepartment of Orofacial Sciences, University of California, San Francisco, USA.ORCID https://orcid.org/0000-0002-5988-0669
Shohei HoriLaboratory of Immunology and Microbiology, Graduate School of Pharmaceutical Sciences, The University of Tokyo, Tokyo, Japan.
Shin-Ichiro FujiiLaboratory for Immunotherapy, RIKEN Center for Integrative Medical Sciences (IMS), Yokohama, Japan.
Hiroyoshi NishikawaDivision of Cancer Immune Multicellular System Regulation, Center for Cancer Immunotherapy and Immunobiology (CCII), Kyoto University Graduate School of Medicine, Kyoto, Japan.ORCID https://orcid.org/0000-0001-6563-9807
Ichiro TaniuchiLaboratory for Transcriptional Regulation, RIKEN Center for Integrative Medical Sciences (IMS), Yokohama, Japan ichiro.taniuchi@riken.jp.ORCID https://orcid.org/0000-0002-9853-9068

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The genome organizer special AT-rich sequence binding protein 1 (SATB1) is critical for the development of T lymphocyte subsets by regulating

Indexed as

CD4-Positive T-LymphocytesMatrix Attachment Region Binding ProteinsT-Lymphocytes, RegulatoryAnimalsForkhead Transcription FactorsMiceMice, Inbred C57BLMice, KnockoutForkhead Transcription FactorsFoxp3 protein, mouseMatrix Attachment Region Binding ProteinsSatb1 protein, mouse

Identifiers

PMID42448570
PMCPMC13370069

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.